TrialJournal of translational medicine2025

Efficacy and safety of third-generation CD19-CAR T cells incorporating CD28 and TLR2 intracellular domains for B-cell malignancies with central nervous system involvement: results of a pivotal trial.

Bailin He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.